Get 20% lifetime commission for referring investors to digrin.com
here.
GUFIC BIOSCIENCES - stock earnings
GUFICBIO.NS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 222.6 million INR | 2.0 billion INR |
| 2023Q3 | 232.1 million INR | 2.1 billion INR |
| 2023Q2 | 206.2 million INR | 2.0 billion INR |
| 2023Q1 | 181.1 million INR | 1.7 billion INR |
| 2022Q4 | 203.4 million INR | 1.8 billion INR |
| 2022Q3 | 202.1 million INR | 1.7 billion INR |
| 2022Q2 | 210.5 million INR | 1.7 billion INR |
| 2022Q1 | 206.2 million INR | 1.7 billion INR |
| 2021Q4 | 210.3 million INR | 1.7 billion INR |
| 2021Q3 | 233.4 million INR | 1.9 billion INR |
| 2021Q2 | 312.1 million INR | 2.5 billion INR |
| 2021Q1 | 184.7 million INR | 1.7 billion INR |
| 2020Q4 | 131.8 million INR | 1.4 billion INR |
| 2020Q3 | 163.3 million INR | 1.2 billion INR |
| 2020Q2 | -37.5 million INR | 541.4 million INR |
| 2020Q1 | 47.2 million INR | 815.9 million INR |
| 2019Q4 | 70.2 million INR | 977.4 million INR |
| 2019Q3 | 43.0 million INR | 860.3 million INR |
| 2019Q2 | 68.1 million INR | 923.9 million INR |
| 2019Q1 | 61.8 million INR | 919.1 million INR |
| 2018Q4 | 58.8 million INR | 876.5 million INR |
| 2018Q3 | 61.9 million INR | 924.2 million INR |
| 2018Q2 | 39.3 million INR | 784.9 million INR |
| 2018Q1 | 30.1 million INR | 774.2 million INR |
| 2017Q4 | 58.4 million INR | 884.2 million INR |
| 2017Q3 | 56.7 million INR | 748.5 million INR |
| 2017Q2 | 35.4 million INR | 602.7 million INR |
| 2017Q1 | 31.2 million INR | 645.2 million INR |
| 2016Q4 | 31.0 million INR | 650.7 million INR |
| 2016Q3 | 26.4 million INR | 643.9 million INR |
| 2016Q2 | 25.5 million INR | 554.5 million INR |
| 2016Q1 | 22.2 million INR | 571.1 million INR |
| 2015Q4 | 24.2 million INR | 561.1 million INR |
| 2015Q3 | 16.5 million INR | 514.2 million INR |
| 2015Q2 | 10.4 million INR | 376.8 million INR |
| 2015Q1 | 11.0 million INR | 353.4 million INR |
| 2014Q4 | 6.8 million INR | 343.4 million INR |
| 2014Q3 | 11.8 million INR | 426.4 million INR |
| 2014Q2 | 11.9 million INR | 391.0 million INR |
| 2014Q1 | 12.6 million INR | 372.3 million INR |
| 2013Q4 | 10.7 million INR | 313.6 million INR |
| 2013Q3 | 11.5 million INR | 290.3 million INR |
| 2013Q2 | 8.0 million INR | 253.9 million INR |
| 2013Q1 | 7.1 million INR | 244.0 million INR |
| 2012Q4 | 8.5 million INR | 247.7 million INR |
| 2012Q3 | 8.9 million INR | 237.5 million INR |
| 2012Q2 | 8.8 million INR | 272.3 million INR |
| 2012Q1 | 981000 INR | 217.1 million INR |
| 2011Q4 | 3.9 million INR | 219.9 million INR |
GUFICBIO.NS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 797.0 million INR | 6.9 billion INR |
| 2022 | 958.4 million INR | 7.8 billion INR |
| 2021 | 442.3 million INR | 4.9 billion INR |
| 2020 | 226.9 million INR | 3.6 billion INR |
| 2019 | 228.6 million INR | 3.5 billion INR |
| 2018 | 160.2 million INR | 3.0 billion INR |
| 2017 | 114.1 million INR | 2.5 billion INR |
| 2016 | 73.2 million INR | 2.0 billion INR |
| 2015 | 41.6 million INR | 1.5 billion INR |
| 2014 | 42.6 million INR | 1.2 billion INR |
| 2013 | 33.3 million INR | 1.0 billion INR |
| 2012 | 15.3 million INR | 835.7 million INR |
| 2011 | 14.6 million INR | 715.8 million INR |
| 2010 | 12.3 million INR | 628.9 million INR |
| 2009 | 8.4 million INR | 516.8 million INR |
| 2008 | 8.8 million INR | 540.9 million INR |
GUFICBIO.NS
Price: ₹344.75
52 week price:
5-year range yield:
Forward Dividend Yield: 0.03%
Payout Ratio: 1.16%
Payout Ratio Range:
Dividend Per Share: 0.10 INR
Earnings Per Share: 8.62 INR
P/E Ratio: 38.99
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 31.8 billion
Average Dividend Frequency: 1
Years Paying Dividends: 16